Pancreatic Cancer Research

ResearcherUniversity of LisbonActive in the last 2 years

Catarina Pinto Reis

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1046-4031; OpenAlex author ID A5052706741. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
8
Papers, trials and grants by year

2017: 1 paper · 2018: 2 papers · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 5

  1. Enhanced Cytotoxicity against a Pancreatic Cancer Cell Line Combining Radiation and Gold Nanoparticles. Last author DOI 10.3390/pharmaceutics16070900↗
  2. Development and Mechanistic Insight into the Enhanced Cytotoxic Potential of Parvifloron D Albumin Nanoparticles in EGFR-Overexpressing Pancreatic Cancer Cells. Last author DOI 10.3390/cancers11111733↗
  3. Development of Parvifloron D-loaded Smart Nanoparticles to Target Pancreatic Cancer. Last author DOI 10.3390/pharmaceutics10040216↗
  4. Emerging therapeutic nanotechnologies in pancreatic cancer: advances, risks and challenges. First author DOI 10.4155/tde-2018-0048↗
  5. Pancreatic Cancer Therapy Review: From Classic Therapeutic Agents to Modern Nanotechnologies. Last author DOI 10.2174/1389200218666170201151135↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ana Rebelo · 2 shared papers, 2017–2018 · strength 0.27
  2. B.C. Ferreira · 1 shared paper, 2024 · strength 0.20
  3. Filipa Mendes · 1 shared paper, 2024 · strength 0.20
  4. Alexandra Martins · 1 shared paper, 2024 · strength 0.20
  5. Ana Santos-Rebelo · 2 shared papers, 2018–2019 · strength 0.15
  6. Yahya Essop Choonara · 1 shared paper, 2019 · strength 0.08
  7. Manuel A. N. Coelho · 1 shared paper, 2018 · strength 0.07
  8. Sílvia Castro Coelho · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.